Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Surgopaedia
Search
Search
Appearance
Create account
Log in
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Editing
Thyroid nodules
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
A discrete lesion within the thyroid gland * Remains a clinical problem to identify which tumours are at risk of causing actual harm to patients if left untreated, and balancing risk of intervention with small risk of the watch-and-wait approach. * Approach: ** USS for TI-RADS ** FNA for Bethesda ** Discharge/surveillance/surgery based on Bethesda == '''Epidemiology''' == * In iodine-replete areas: ** 20-65% of patients will have some sort of nodule if you ultrasound them ** 5% of women and 1% of men will have a palpable thyroid nodule * 5-10% of nodules will be malignant, but the vast majority do not require surgical intervention * Diagnosis of thyroid nodules has increased dramatically over the past 30 years, mostly due to the increased pickup rate of <1cm PTCs (microcarcinomas). * No change in mortality rate == '''Risk factors for cancer:''' == * History ** Rapid growth ** First-degree relative with thyroid cancer ** Head and neck radiation - takes between 6-35 years to develop into cancer ** Total body irradiation ** Thyroid cancer syndromes e.g. MEN-2, FAP, Cowden's disease ** Young patient <20yo - think medullary cancer, but not necessarily likely to be that ** Age >70yo ** Male sex * Exam: ** Fixed, hard mass ** Obstructive symptoms ** Vocal cord paralysis ** Nodules >3-4cm == '''Pathophysiology''' == * Colloid nodules * Degenerative cysts * Nodular hyperplasia * Follicular or Hurthle cell adenomas * Malignancies - see separate topic == '''Presentation''' == * Majority benign and asymptomatic * Consider features of hyper-functioning/toxic nodule (hyperthyroidism - see separate topic) == '''Initial investigation''' == * TFTs: TSH, T3/T4 * Calcium, PTH, vitamin D * Optional: (mostly if TSH is abnormal) ** TRABS - exclude Graves disease ** Anti-TPO Ab - Hashimoto's ** Thyroid antibodies ** Calcitonin - only if suspected medullary cancer ** Genetic testing - e.g. BRAF == '''Imaging:''' == * USS first-line: ** Nodules picked up on examination ** Incidental nodules found through other modalities * CT to evaluate for retrosternal extension or metastases - don't generally give IV contrast, since it will preclude the ability to give radioactive iodine * Nuclear medicine thyroid scintigraphy ** Indication - hyperthyroidism and thyroid nodule ** Looking for a toxic nodule * Incidental PET-positive nodule has quite a high rate of malignancy - exact number varies from study to study - could say 40% ** Have a lower threshold to biopsy rather than purely following TIRADS ** ATA guidelines suggest biopsy anything PET-positive >1cm (equivalent to TR5). They will almost always be >1cm to show up on PET anyway. ** Differentials: colloid nodule, follicular adenomas (functioning and non-functioning), MNG, nodular thyroiditis (subacute and chronic lymphocytic), degenerative thyroid cyst, malignancy, parathyroid, lipoma, paraganglioma, very rarely infiltrative disorders (e.g. haemochromatosis) '''Ultrasound findings:''' * Look at: (those in bold have higher specificity for cancer) ** Echogenicity (hypoechoic is suspicious) ** '''Calcifications and microcalcifications''' ** Shape '''(taller than wide, with irregular margins - since malignancies tend to cross tissue planes)''' ** Vascularity ** Composition ** Nodes ** Reassuring for benign - spongiform pattern, purely cystic appearance * Elastography (measuring stiffness of thyroid nodule using USS) is not currently recommended for routine use TI-RADS: {| class="wikitable" |'''Composition''' | |'''Echogenicity''' | |'''Shape''' | |'''Margin''' | |'''Echogenic foci''' | |- |Cystic or almost completely cystic |0 |Anechoic |0 |Wider-than-tall |0 |Smooth |0 |None or large comet-tail artifacts |0 |- |Spongiform |0 |Hyperechoic or isoechoic |1 |Taller-than-wide |3 |Ill-defined |0 |Macrocalcifications |1 |- |Mixed cystic and solid |1 |Hypoechoic |2 | | |Lobulated or irregular |2 |Peripheral (rim) calcifications |2 |- |Solid or almost completely solid |2 |Very hypoechoic |3 | | |Extrathyroidal extension |3 |Punctate echogenic foci |3 |} {| class="wikitable" | |'''Points''' |'''Malignancy risk (%)''' |'''Biopsy threshold (mm)''' |- |'''TR1''' |0 |0.3 |No biopsy |- |'''TR2''' |2 |1.5 |No biopsy |- |'''TR3''' |3 |4.8 |25 |- |'''TR4''' |4 to 6 |9.1 |15 |- |'''TR5''' |7+ |35.0 |10 |} '''ATA:''' Can use ATA score or TI-RADS for risk-stratifying thyroid nodules. Both independently validated but TI-RADS currently thought to be better. * These will decide whether or not to proceed with FNA * Also incorporate clinical assessment - FNA can still be considered in nodules <1cm or not otherwise meeting criteria with: ** Strong family history thyroid cancer ** Young patient ** Therapeutic head and neck radiation ** Preference for FNA over observation ** Location of nodule in thyroid ** Lymphadenopathy ** Immobile, fixed mass with voice changes == '''Cytopathological risk stratification''' == * FNA is preferred technique - gives good enough answer to render larger biopsies such as CNB obsolete, unless lymphoma is a high possibility ** Can technically be done blind, but USS-guided is obviously better ** Mean sensitivity >80%, mean specificity >90% ** 23-27-gauge needle ** Confirm adequacy of specimen at time of biopsy (6 groups of well-visualised follicular cells, 10 cells per group) * Contraindications to FNA: ** Prohibitive surgical risk ** Already proceeding with thyroidectomy ** Extreme elderly with small nodules * Use BETHESDA system for thyroid cytopathology (last updated 2017; below) ** Categories 2 and 6 are highly accurate, with error rate <3% ** Others quite variable - see ranges of malignancy below ** Traditional recommendation for 3 and 4 lesions to have lobectomy, but efforts now to reduce that rate, since most are benign. Molecular testing may help. * Molecular testing ** Complex field. Tests can be considered as either 'rule-in' or 'rule-out' tests. ** Most useful for Bethesda 3 and 4 nodules ** Take into account the holistic picture and order appropriately. ** Afirma Gene Expression Classifier - mostly rule-out - 90% sensitivity, but specificity 50% for Bethesda 3 and 4 nodules ** Afirma Genomic Sequence Classifier - se 91% sp 68%. Particularly poor performance for Hurthle cell adenoma and carcinoma. ** ThyroSeq v2 - se >90% sp >90% in early studies, but subsequent validation outcomes were poor. ** ThyroSeq v3 - se 94% sp 82% in Bethesda 3 + 4, and better performance in Hurthle cell. Costs about $2,100 per nodule in Australia, with no medicare rebate, and takes a couple of weeks. {| class="wikitable" |'''Bethesda class''' |'''Diagnostic category''' |'''Cancer risk''' |- |I |Nondiagnostic (unsatisfactory) |5 to 10% |- |II |Benign |0 to 3% |- |III |Atypia of undetermined significance (AUS) or follicular lesion of undetermined significance (FLUS) |10 to 30% |- |IV |Follicular neoplasm (or suspicious for follicular neoplasm, also encompassing Hurthle cell neoplasm) |25 to 40% |- |V |Suspicious for malignancy |50 to 75% |- |VI |Malignant |97 to 99% |} # Repeat FNA, then excisional biopsy if still indeterminate ## Some surgeons say 2x FNA then 1x core biopsy then consider excision # Repeat follow-up 2-3 years is probably standard for these nodules # Cancer risk is overstated for this group. Consider clinical and radiographical factors (as in, were you expecting a higher Bethesda score based on the TI-RADS?). Consider repeat FNAB or lobectomy. # Typically excised. Mostly found to be follicular adenomas or adenomatoid nodules of MNG. Can't tell the difference between benign and malignant follicular lesions on FNA - need to see whether there is capsular invasion. # Surgical resection # Surgical resection, unless widely metastatic. = '''Management options''' = * Discharge * Surveillance * Surgery == '''Management of thyroid nodules in pregnancy''' == * If symptomatic of severe compression - immediate surgery * If asymptomatic, USS and FNA as usual ** Well-differentiated cancer could have second trimester surgery or defer until post-partum, depending on risk profile ** Anaplastic or MTC would generally have immediate surgery ** Suspicious FNA could either have second-trimester surgery or deferred workup == '''Follow-up for nodules that don't meet FNA criteria/benign''' == * <1cm with suspicious characteristics: 6-12 months * Low-intermediate suspicion on USS - 12-24 months * Very low-risk nodules: 2-3 years * Benign: 1-3 years depending on risk factors * 2x FNAs with both benign: No further USS indicated == '''Surgery''' == * Indications for surgery: ** Concern for malignancy ** Hyperfunction ** Local compressive symptoms * '''Lobectomy vs thyroidectomy (ATA guidelines 2016)''' ** >4cm differentiated cancer: total thyroidectomy ** 1-4cm without clinical evidence of extrathyroidal disease or nodal mets or high-risk features: Either total thyroidectomy or lobectomy are appropriate. Controversial. ** <1cm: surveillance or lobectomy * Favour total thyroidectomy in ** Age >45 ** Contralateral thyroid nodules ** Hx radiation exposure ** Familial DTC ** Patient preference == Follow-up post-op: == * Note that following lobectomy, if pathology is malignant, TSH will need to be maintained <2mIU/L [[Category:Endocrine]]
Summary:
Please note that all contributions to Surgopaedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Surgopaedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Thyroid nodules
Add topic